PER 5.00% 10.5¢ percheron therapeutics limited

Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-7

  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    told everyone the CTA’s hadn’t been submitted and likely the trial likely starts in 2023. Boy, did I get flak for it.

    we can kiss goodbye to the PRV.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.